For over 70 years, Polycystic Ovary Syndrome (PCOS) has defined a condition that affects millions of women worldwide. Yet the name itself may be fundamentally misleading, which is why some researchers now propose Polycystic Metabolic Syndrome (PMOS) as a more accurate descriptor.

The Problem with "PCOS"

The term "Polycystic Ovary Syndrome" emphasizes the reproductive symptom—cysts on the ovaries—rather than the underlying metabolic dysfunction. However, not all women with PCOS have polycystic ovaries, and many with polycystic ovaries don't have PCOS. This naming has led to decades of misdiagnosis, delayed treatment, and misguided medical advice focused solely on reproductive health.

A Metabolic Condition at Heart

Modern endocrinology now understands PCOS as a metabolic disorder first, with reproductive symptoms as secondary manifestations. Insulin resistance, inflammation, and hormonal dysregulation are the core drivers. Renaming it to reflect this metabolic reality could shift how doctors diagnose and treat the condition.

The Impact of Better Naming

A name change to PMOS would encourage earlier intervention focused on metabolic health rather than waiting for ovarian changes. It would validate the experiences of lean women with PCOS who are often dismissed because they don't fit the "overweight" stereotype. It would also align medical understanding with the latest research on insulin sensitivity and inflammation.

What This Means for Patients

For women living with this condition, a name change signals hope: the recognition that this is not just about reproductive health, but about systemic metabolic wellness. It opens doors to more comprehensive treatment plans that address root causes rather than just managing symptoms.

Explore the full history and implications at Sage & Soul.